38 studies found for:    Open Studies | "Cerebellar Diseases"
Show Display Options
Rank Status Study
1 Recruiting Emotional Communication Disorders in Cerebellar Disease
Condition: Cerebellar Diseases
Interventions: Behavioral: Testing of emotional communication ability;   Procedure: magnetic resonance imaging (MRI) of the brain
2 Not yet recruiting Citocoline for Treatment of FXTAS
Condition: Balance and Cognitive Deficits in Fragile X-associated Tremor Ataxia Syndrome
Intervention: Drug: citocoline
3 Recruiting Clinical and Molecular Investigations Into Ciliopathies
Conditions: Autosomal Recessive Polycystic Kidney Disease;   Congenital Hepatic Fibrosis;   Caroli's Disease;   Polycystic Kidney Disease;   Joubert Syndrome;   Cerebro-Oculo-Renal Syndromes;   COACH Syndrome;   Senior-Loken Syndrome;   Dekaban-Arima Syndrome;   Cogan Oculomotor Apraxia;   Nephronophthisis;   Bardet-Biedl Syndrome;   Alstrom Syndrome;   Oral-Facial-Digital Syndrome
4 Not yet recruiting A TAK-831-1001, Single and Multiple Rising Dose Study in Healthy Participants
Condition: Schizophrenia, Cerebellar Ataxia
Interventions: Drug: TAK-831;   Drug: TAK-831 Placebo
5 Recruiting Efficacy and Safety Study of Mesenchymal Stem Cells (Stemchymal®) in Polyglutamine Spinocerebellar Ataxia
Condition: Cerebellar Ataxia
Interventions: Biological: Stemchymal®;   Procedure: Excipients
6 Not yet recruiting Biomarkers in Friedreich's Ataxia
Condition: Friedreich's Ataxia
7 Not yet recruiting Functional and Structural Imaging and Motor Control in Spinocerebellar Ataxia
Condition: Spinocerebellar Ataxia
Interventions: Behavioral: Error-reduction;   Behavioral: International Cooperative Ataxia Rating Scale;   Behavioral: Scale for the Assessment and Rating of Ataxia
8 Recruiting A First in Human Study of RT001 in Patients With Friedreich's Ataxia
Condition: Friedreich's Ataxia
Interventions: Drug: RT001;   Drug: RT001 comparator
9 Recruiting The EUROSCA Natural History Study
Condition: Spinocerebellar Ataxia
10 Not yet recruiting Methylprednisolone Treatment of Friedreich Ataxia
Condition: Friedreich Ataxia
Intervention: Drug: Methylprednisolone
11 Recruiting Safety, Tolerability and Efficacy of ACTIMMUNE Dose Escalation in Friedreich's Ataxia
Condition: Friedreich's Ataxia
Interventions: Drug: Interferon γ-1b;   Drug: Placebo
12 Recruiting Characterization of the Cardiac Phenotype of Friedreich's Ataxia (FRDA)
Condition: Friedreich's Ataxia
Interventions: Procedure: Cardiac magnetic resonance imaging (CMR);   Procedure: Exercise-stress test;   Procedure: Echocardiogram (ECHO);   Procedure: Cardiac-related blood studies
13 Not yet recruiting Pancreatic Cancer Screening of High-Risk Individuals in Arkansas
Conditions: Pancreatic Neoplasms;   Peutz-Jegher's Syndrome;   BRCA1 Gene Mutation;   BRCA2 Gene Mutation;   Ataxia Telangiectasia;   Familial Atypical Mole-Malignant Melanoma Syndrome;   Colorectal Neoplasms, Hereditary Nonpolyposis;   Hereditary Pancreatitis
Interventions: Other: Pancreatic Cancer Screening Pathway 1;   Other: Pancreatic Cancer Screening Pathway 2
14 Recruiting An Open-label Trial of Intravenous Immune Globulin (IVIG)in Treating Spinocerebellar Ataxias
Condition: Spinocerebellar Ataxias
Intervention: Drug: Intravenous Immune Globulin (IVIG)
15 Recruiting Oxidative Stress, Low Grade Inflammation, Tissue Breakdown and Biomarkers in Cerebrospinal Fluid of A-T
Condition: Ataxia Telangiectasia
Intervention: Procedure: Lumbar puncture
16 Recruiting Impact of Cerebellar Mass Resection on Pain Processing
Condition: Cerebellar Neoplasm
Interventions: Device: Medoc Advanced Medical Systems PATHWAY Model ATS;   Procedure: Cold water bath;   Device: MRI scanner;   Other: Questionnaires
17 Recruiting RTA 408 Capsules in Patients With Friedreich's Ataxia - MOXIe
Condition: Friedreich Ataxia
Interventions: Drug: Omaveloxolone Capsules, 2.5 mg;   Drug: Omaveloxolone Capsules, 5 mg;   Drug: Omaveloxolone Capsules, 10 mg;   Drug: Placebo;   Device: Omaveloxolone Capsules, 20 mg;   Drug: Omaveloxolone Capsules, TBD mg
18 Not yet recruiting Cell-Based Approaches For Modeling and Treating Ataxia-Telangiectasia
Condition: Ataxia-Telangiectasia (A-T)
Interventions: Other: with gene correction;   Other: without gene correction
19 Recruiting Machado-Joseph Disease in Israel
Condition: Spinocerebellar Ataxia 3
20 Recruiting Study To Assess Safety, Tolerability and Efficacy of Intravenous Cabaletta in Patients With Machado-Joseph Disease
Condition: Machado-Joseph Disease / Spinocerebellar Ataxia 3
Intervention: Drug: Cabaletta for IV infusion once weekly during 24 weeks

   Previous Page Studies Shown (1-20) Next Page (21-38) Show next page of results    Last Page
Indicates status has not been verified in more than two years